Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Aurinia Pharmaceuticals Inc. (AUPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/10/2023 |
SC 13D/A
| ILJIN SNT Co., Ltd. reports a 5% stake in Aurinia Pharmaceuticals Inc. |
| 01/20/2023 |
SC 13D/A
| ILJIN SNT Co., Ltd. reports a 5.1% stake in Aurinia Pharmaceuticals Inc. |
| 01/06/2023 |
SC 13D/A
| ILJIN SNT Co., Ltd. reports a 5.1% stake in Aurinia Pharmaceuticals Inc. |
| 03/03/2022 |
SC 13D/A
| ILJIN SNT Co., Ltd. reports a 5.8% stake in Aurinia Pharmaceuticals Inc. |
| 03/10/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/27/2021 |
SC 13D/A
| ILJIN SNT Co., Ltd. reports a 4.5% stake in Aurinia Pharmaceuticals Inc. |
| 01/26/2021 |
SC 13D/A
| ILJIN SNT Co., Ltd. reports a 8.3% stake in Aurinia Pharmaceuticals Inc. |
| 10/09/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/23/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/18/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/10/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/09/2019 |
SC 13D/A
| ILJIN SNT Co., Ltd. reports a 11.9% stake in Aurinia Pharmaceuticals Inc. |
| 12/06/2019 |
SC 13D/A
| ILJIN SNT Co., Ltd. reports a 13.1% stake in Aurinia Pharmaceuticals Inc. |
| 11/13/2019 |
SC 13D/A
| ILJIN SNT Co., Ltd. reports a 14.5% stake in Aurinia Pharmaceuticals Inc. |
| 06/03/2019 |
SC 13D/A
| ILJIN SNT Co., Ltd. reports a 14.5% stake in Aurinia Pharmaceuticals Inc. |
| 01/18/2019 |
SC 13D/A
| DUGGAN ROBERT W reports a 5% stake in Aurinia Pharmaceuticals Inc. |
| 10/23/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/24/2017 |
SC 13D/A
| ILJIN Life Science Co., Ltd. reports a 17.4% stake in Aurinia Pharmaceuticals Inc. |
| 01/05/2017 |
SC 13D/A
| ILJIN Life Science Co., Ltd. reports a 16.6% stake in Aurinia Pharmaceuticals Inc. |
|
|